BRIEF — Nxera Pharma — Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia — Pacific Markets

Oct 14 (Reuters) — Nxera Pharma Co., Ltd.: Entered Into Exclusive License, Supply And Commercialization Agreement With Synmosa For Quviviq Across Eight Asia-pacific Markets Source text:... Further company coverage: 4565.T